New Right To Try Bill Fails To Persuade
US House rejects tempered legislation as many stakeholders remain opposed – but vote allows members to signal to the Trump administration that they tried.
You may also be interested in...
Gottlieb: Lack Of Compromise On Right-To-Try Bill Is 'Interesting Lesson In Politics' For Stakeholders
In interview with the Pink Sheet, former US FDA commissioner Scott Gottlieb said that opposition to the modified House version of the right-to-try legislation ultimately led to the less favorable Senate bill becoming law.
Proponent says companies ready to use new expanded access pathway that US FDA will have essentially no involvement in.
US House passage sends legislation back to Senate, where it may not garner widespread support.